Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1995 1
1997 1
1998 4
1999 2
2000 2
2001 2
2002 1
2003 2
2004 2
2005 4
2006 6
2007 15
2008 7
2009 6
2010 9
2011 4
2012 6
2013 3
2014 3
2015 1
2016 10
2017 7
2018 8
2019 12
2020 7
2021 5
2022 6
2023 16
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
The Alzheimer Disconnectome.
Brodtmann A, Beversdorf DQ. Brodtmann A, et al. Among authors: beversdorf dq. Neurology. 2023 May 30;100(22):1037-1038. doi: 10.1212/WNL.0000000000207303. Epub 2023 Apr 17. Neurology. 2023. PMID: 37068955 No abstract available.
Randomized controlled trial of propranolol on social communication and anxiety in children and young adults with autism spectrum disorder.
Beversdorf DQ, Ferguson B, Hunter S, Hirst K, Lolli B, Bellesheim KR, Barton AU, Muckerman J, Takahashi N, Selders K, Holem R, Sohl K, Dyke P, Stichter J, Mazurek M, Kanne S. Beversdorf DQ, et al. Psychopharmacology (Berl). 2024 Jan;241(1):19-32. doi: 10.1007/s00213-023-06452-1. Epub 2023 Dec 13. Psychopharmacology (Berl). 2024. PMID: 38086927 Clinical Trial.
Author Response.
Beversdorf DQ, Lennon V, Mehler M, Roos R. Beversdorf DQ, et al. Neurology. 2016 Feb 9;86(6):585-6. Neurology. 2016. PMID: 27280229 No abstract available.
Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m).
Beversdorf DQ, Anagnostou E, Hardan A, Wang P, Erickson CA, Frazier TW, Veenstra-VanderWeele J. Beversdorf DQ, et al. Front Psychiatry. 2023 Jan 19;13:1079006. doi: 10.3389/fpsyt.2022.1079006. eCollection 2022. Front Psychiatry. 2023. PMID: 36741580 Free PMC article. No abstract available.
137 results